-
EP3325645
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3325645
| EP3325645 - METHODS FOR THE PROGNOSIS AND TREATMENT OF ENDOMETRIAL CARCINOMA [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.12.2020 Database last updated on 12.07.2024 | |
| Former | Grant of patent is intended Status updated on 29.03.2020 | ||
| Former | Examination is in progress Status updated on 31.01.2019 | ||
| Former | Request for examination was made Status updated on 27.04.2018 | ||
| Former | The international publication has been made Status updated on 27.01.2017 | Most recent event Tooltip | 25.12.2020 | Application deemed to be withdrawn | published on 27.01.2021 [2021/04] | Applicant(s) | For all designated states INSERM (Institut National de la Santé et de la Recherche Médicale) 101, rue de Tolbiac 75013 Paris / FR | For all designated states Université Paris Descartes 12, rue de l'Ecole de Médecine 75006 Paris / FR | For all designated states Assistance Publique-Hôpitaux de Paris (APHP) 3, avenue Victoria 75004 Paris / FR | [2018/22] | Inventor(s) | 01 /
FORGEZ, Patricia Inserm UMRS 1007 - Université Paris Descartes 45 Rue des Saints-Pères 75006 Paris / FR | 02 /
GOMPEL, Anne Inserm UMRS 1007 - Université Paris Descartes 45 Rue des Saint Pères 75006 Paris / FR | [2018/22] | Representative(s) | Inserm Transfert PariSanté Campus 10 rue d'Oradour-sur-Glane 75015 Paris / FR | [N/P] |
| Former [2018/22] | Collin, Matthieu Inserm-Transfert Paris Biopark 7, rue Watt 75013 Paris / FR | Application number, filing date | 16739453.5 | 13.07.2016 | [2018/22] | WO2016EP66693 | Priority number, date | EP20150306170 | 17.07.2015 Original published format: EP 15306170 | [2018/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017012961 | Date: | 26.01.2017 | Language: | EN | [2017/04] | Type: | A1 Application with search report | No.: | EP3325645 | Date: | 30.05.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.01.2017 takes the place of the publication of the European patent application. | [2018/22] | Search report(s) | International search report - published on: | EP | 26.01.2017 | Classification | IPC: | C12Q1/6886, A61K39/00, G01N33/574 | [2020/16] | CPC: |
A61K39/395 (EP,US);
A61P35/00 (EP,US);
C12Q1/6886 (EP,US);
G01N33/57442 (EP,US);
C12Q2600/118 (EP,US);
C12Q2600/158 (EP,US);
|
| Former IPC [2018/22] | C12Q1/68, A61K39/00, G01N33/574 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/22] | Title | German: | VERFAHREN ZUR PROGNOSE UND BEHANDLUNG VON ENDOMETRIUMKARZINOMEN | [2018/22] | English: | METHODS FOR THE PROGNOSIS AND TREATMENT OF ENDOMETRIAL CARCINOMA | [2018/22] | French: | PROCÉDÉS POUR LE PRONOSTIC ET LE TRAITEMENT DE CARCINOME ENDOMÉTRIAL | [2020/16] |
| Former [2018/22] | MÉTHODES POUR LE PRONOSTIC ET LE TRAITEMENT DU CARCINOME DE L'ENDOMÈTRE | Entry into regional phase | 17.01.2018 | National basic fee paid | 17.01.2018 | Designation fee(s) paid | 17.01.2018 | Examination fee paid | Examination procedure | 17.01.2018 | Amendment by applicant (claims and/or description) | 17.01.2018 | Examination requested [2018/22] | 17.01.2018 | Date on which the examining division has become responsible | 01.02.2019 | Despatch of a communication from the examining division (Time limit: M04) | 29.05.2019 | Reply to a communication from the examining division | 30.03.2020 | Communication of intention to grant the patent | 11.08.2020 | Application deemed to be withdrawn, date of legal effect [2021/04] | 08.09.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2021/04] | Fees paid | Renewal fee | 24.07.2018 | Renewal fee patent year 03 | 22.07.2019 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.07.2020 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]US2005112678 (YANG JIANXIN [US]) [I] 6-10 * claims 45-49 *; | [Y]WO2009127619 (INST NAT SANTE RECH MED [FR], et al) [Y] 1-5 * figure 2; example 1; claim 1 *; | [Y]WO2010079158 (INST NAT SANTE RECH MED [FR], et al) [Y] 1-5 * page 23; claim 1 *; | [Y] - FERREIRA T R M ET AL, "479 The functional role of ADAM23 on SKMel-37 melanoma cells", EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, PERGAMON, OXFORD, GB, vol. 8, no. 5, ISSN 1359-6349, (20100601), page 122, (20100601), XP027105710 [Y] 1-5 * paragraph [0476] * |